BD Regional Block Needles Recalled for Missing Contraindications in Instructions
Becton Dickinson is recalling BD Regional Block Needles because the instructions for use lack general contraindications, as advised by the European Notified Body.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text identifies the issue as a documentation error (missing contraindications in the IFU) without reporting any injuries, illnesses, or deaths. This aligns with the 'Moderate' criteria for minor labeling/documentation errors.
Plain-English summary
Becton Dickinson & Company is recalling BD Regional Block Needles 22G x 1.50in (Catalog No. 408348). The recall involves 105,880 units distributed across 18 U.S. states and four foreign countries: Australia, Canada, Belgium, and Singapore.
The recall was initiated after the European Notified Body, NSAI, advised that the instructions for use (IFU) need to be updated to include general contraindications. The agency has classified this as a Class II recall. All lots within the expiration date are affected, identified by UDI (01)50382904083484.
Healthcare providers and facilities should stop using the affected needles and contact Becton Dickinson for further instructions. Consumers should not use these products and should return them to the point of purchase or contact the manufacturer.
The recalled product
- Product
- BD Regional Block Needles 22G x 1.50in (50 units/cs.). Indicated for administration of medications to affect anesthesia or analgesia to a specific anatomical location (region). Catalog No. 408348
- Manufacturer
- Becton Dickinson & Company
- Category
- Medical Device — Needles
- Hazard
- Affected units
- 105,880
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiration date UDI: (01)50382904083484
Distribution
Part of a larger recall action
This product is one of 2 recalled by Becton Dickinson & Company under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Becton Dickinson & Company
See all →- SevereBD combined Whitacre and Quincke spinal trays recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 24 gauge spinal trays recalled over bupivacaine quality issues
FDA (Devices) · 2026-06-10
- SevereBD Whitacre 22G spinal trays recalled in Huons bupivacaine sub-recall
FDA (Devices) · 2026-06-10
- SevereBD Whitacre spinal trays across nine catalog numbers recalled over bupivacaine
FDA (Devices) · 2026-06-10
- SevereBD spinal trays recalled as a sub-recall of Huons bupivacaine
FDA (Devices) · 2026-06-10
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02